Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.
Franzen S, Smith JE, van den Berg E, Rivera Mindt M, van Bruchem-Visser RL, Abner EL, Schneider LS, Prins ND, Babulal GM, Papma JM.
Franzen S, et al. Among authors: abner el.
Alzheimers Dement. 2022 Apr;18(4):810-823. doi: 10.1002/alz.12433. Epub 2021 Sep 30.
Alzheimers Dement. 2022.
PMID: 34590409
Free PMC article.
Review.